LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases.
about
Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescenceLRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergyLrig2-deficient mice are protected against PDGFB-induced gliomaCross-repressive interactions between Lrig3 and netrin 1 shape the architecture of the inner ear.Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.LRIG2 expression and prognosis in non-small cell lung cancer.The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressorThe LRIG family: enigmatic regulators of growth factor receptor signaling.Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing FieldKey differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.Deregulation of epidermal stem cell niche contributes to pathogenesis of nonhealing venous ulcersLRIG1 as a potential novel marker for neoplastic transformation in ocular surface squamous neoplasiaLoss of Lrig1 leads to expansion of Brunner glands followed by duodenal adenomas with gastric metaplasia.LRIG and cancer prognosis.Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling.LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell CarcinomaSuppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer.LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.Interfering with stem cell-specific gatekeeper functions controls tumour initiation and malignant progression of skin tumours.A stem cell gene expression profile of human squamous cell carcinomas.Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.Role and mechanism of action of LRIG1 in ovarian cancer cell line and VP16 drug-resistant cell line.Lrig1 Expression in Human Sebaceous Gland Tumors.Endocytosis and cancer.A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer.Immunohistochemical analyses point to epidermal origin of human Merkel cells.
P2860
Q24670890-86B81592-F607-4B4C-B34A-588331004551Q24681561-5310E21E-5A62-416A-92B8-A30DD038A7AEQ28506352-D18EC2C5-9CD5-4D7C-AFBC-E0B4CD50EDAEQ30435788-0CF562A1-B526-4556-88AF-150F60634397Q33529059-D210F16F-469A-4085-9A01-C57825924BF8Q33844052-38578456-2DAA-459B-9D93-AA0EF322C2DDQ34264864-EA8013FD-0647-4D77-8F72-03DE29484295Q34276176-CF1E60BE-409E-46C1-8798-BD2E3368C1D1Q34421021-196886C4-2EA3-4EE3-8DAB-930F51813711Q34996130-FD2C3837-18AB-42C9-B18C-6908F058E508Q35066454-21E8CF34-DC65-4EBD-85B8-A27E430BBA1BQ35087567-5DFD7BCF-3DAB-41E4-98BD-4C3A2AF438ACQ35141723-CADC2904-B122-43AC-89CE-F11485020536Q35236469-898B83A4-79CD-4C13-8758-06C95592B6FCQ35626430-0AD6C904-FA0C-47E5-A06D-32C1E5DDED5CQ36165800-22A27684-A423-48C0-9E97-74FC2247F166Q36421275-2139A1F5-F790-4157-A6B9-6BAFFBFA2F30Q36723368-4A75F215-C565-4A42-A555-7C362D99D3D3Q36771508-38D0FBB5-EF96-46DE-BFD2-4574E0704964Q37003688-1F6B2A0B-E9EA-491C-8879-7B4C047E79E7Q37249599-D476C414-5A9D-46C5-86F7-B34300385524Q37328598-FF649AB3-0479-4C9E-9968-185CB0391FA9Q37430574-79024AB6-871F-42F4-AB22-D2627B2795E6Q37681779-4B469B76-D557-4B9F-9D5B-3954329D1A08Q38096295-084340DD-AA11-41DF-AED5-C97C0D0A403CQ38512194-7B845F38-FCA7-43EB-91D3-4529D788029CQ39052075-2628A27E-4264-4001-A98A-9C1E26DFA451Q39956932-B890AAB1-5353-4624-BB45-79918CFAD70CQ40070276-78C6DF78-E94E-43B4-B976-B40E568F803BQ41389592-F37DDDA7-DC4D-4247-B6DD-D07DAAA8E7B3Q41966811-4F9B68FF-9690-49AB-945F-0A9278FDFC73Q42869980-16C70011-6214-4BE5-93B4-0EA58C5CD7D1Q47215868-21DEF57E-665D-4BEB-BA6A-641B4E96BCD0Q48578773-CB2CCEEB-700A-429B-88E8-117B27DDFEF3Q50047531-B63350C7-532C-466D-B720-FAC720B9C704Q54508851-3D662D84-CFEC-4654-B7E4-9FB0D4912AC3
P2860
LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@en
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@nl
type
label
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@en
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@nl
prefLabel
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@en
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@nl
P2093
P1433
P1476
LRIG-1 provides a novel progno ...... hemical analysis for 38 cases.
@en
P2093
Atsushi Tanemura
Satoshi Itami
Shigeki Inui
Tomohiko Nagasawa
P304
P356
10.1111/J.1524-4725.2005.31108
P577
2005-04-01T00:00:00Z